Iohexol Injection USP 300mg-50ml
Product Description
Swasthya Healthcare Private Limited
-
IN -
2022On CPHI since
-
100 - 249Employees
Company types
Primary activities
Categories
Swasthya Healthcare Private Limited
-
IN
-
2022On CPHI since
-
100 - 249Employees
Company types
Primary activities
More Products from Swasthya Healthcare Private Limited (2)
-
Product Fingolimod Capsules 0.5 mg
Fingolimod, a sphingosine-1-phosphate (S1P) receptor modulator, is an effective therapy for Relapsing-Remitting Multiple Sclerosis (RRMS) that reduces relapses, slows disability progression, and enhances patient quality of life.
Mechanism of Action (MOA): Modulates S1P receptors, which ... -
Product Leuprolide Depot Injection 22.5 mg
Mechanism of Action (MOA): Leuprolide acts as a GnRH agonist, initially stimulating but eventually suppressing LH & FSH secretion, leading to decreased testosterone in men and estrogen in women.
Therapeutic UsProstate Cancer – Advanced and hormone-dependent cases
Endometriosis – Sympto...
Frequently Viewed Together
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance